Sentiment · TMO
Lobbying Spend for TMO
AI-generated plain-English read of lobbying spend for TMO. Updated daily.
Moderate lobbying, declining
highModerate spend winding down. Likely resolved the issue that drove it, or pulling back resources. No clean signal. Read other channels.
What will probably happen
- Easing spend typically means prior policy battles are resolved or de-prioritized. Neutral from a risk standpoint; investigate whether the issue resolved favorably.
- Spend is spread across many issue areas: the company has diverse regulatory exposure and is fighting on multiple fronts simultaneously.
What to do
- If you HOLD this stock
- Lobbying is pulling back. If the policy issue resolved favorably, this is a positive. If unresolved, investigate before adding exposure.
- If you're EVALUATING this stock
- No sharp lobbying signal to factor into entry timing. Evaluate on fundamentals.
- If you trade OPTIONS
- No clean options signal derived from this lobbying read.
17 quarters of history with $12.32M in total spend: sufficient data for a reliable trajectory read.
Technical details
Technical analysis
- Spend tier
- Moderate
- Trajectory
- Declining
- Issue concentration
- Broad
- Registrant base
- In house
- Last quarter
- $721.0K
- Last 4Q total
- $2.55M
- Prior 4Q total
- $3.45M
- Quarters on record
- 17
- Unique issue areas
- 11
- Unique registrants
- 7
- Top issue area
- HEALTH ISSUES (35% of spend)
- Top registrant
- THERMO FISHER SCIENTIFIC INC. (76% of spend)
Key levels
| Level | Value |
|---|---|
| last quarter amount | 721,000 |
| last 4q total | 2,551,000 |
| prior 4q total | 3,446,000 |
| total amount | 12,317,000 |
| top issue pct | 0.348 |
| top registrant pct | 0.759 |
Caveats
- Lobbying disclosures are quarterly and reflect activity already past. The signal is structural, not timing.
- The primary registrant appears to be an in-house government-affairs operation. In-house lobbying may not be captured in full by third-party disclosure data.